Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis. BMC cardiovascular disorders Shiffman, D., Perez, M. V., Bare, L. A., Louie, J. Z., Arellano, A. R., Devlin, J. J. 2015; 15 (1): 104-?

View details for DOI 10.1186/s12872-015-0100-7

View details for PubMedID 26419225